Evonik Acquires Dutch Hydrogen Peroxide Producer

Key highlights
  • Evonik completed the acquisition of PeroxyChem Netherlands B.V. on October 30, 2015.
  • The acquisition includes the Delfzijl plant and its H2O2 business.
  • Evonik's H2O2 capacity in Europe will exceed 250,000 metric tons per year.
  • Evonik already produces H2O2 in Germany, Belgium, and Austria.

Acquisition Completion

Evonik has finalized the acquisition of PeroxyChem Netherlands B.V., Delfzijl, making it a fully owned subsidiary of the Evonik Group. The transaction was completed on October 30, 2015, transferring the H2O2 business, including the production site and employees, to Evonik. The company has been renamed Evonik PeroxyChem Netherlands B.V.

Strategic Expansion

The addition of the Delfzijl plant strengthens Evonik’s hydrogen peroxide business, enabling the company to meet anticipated regional demand and improve customer service. This acquisition increases Evonik’s hydrogen peroxide production capacity in Europe to over 250,000 metric tons per year.

Existing Production Sites

Evonik already operates hydrogen peroxide production facilities in Rheinfelden, Germany; Antwerp, Belgium; and Weißenstein, Austria. The new acquisition complements these existing sites, further solidifying Evonik’s position in the European market.

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

30 July 2026
Evonik‑licensed Leshan H₂O₂ megaplant (Fuhua) starts production

200 kt/yr industrial H₂O₂ plant began operations on 18 June 2026; will sell to the merchant market and supply a JV for further purification into specialty grades.

11 June 2026
Evonik launches low‑carbon peracetic acid for Europe

Peracetic acid produced using bio-based acetic acid and low‑carbon hydrogen peroxide; mass‑balance accounting lets customers lower Scope 3 emissions transparently.

23 April 2026
Evonik and Fuhua complete Leshan specialty H2O2 plant

Leshan H2O2 plant finished; entering trial production for specialty grades serving PV, semiconductors, packaging, pharma. Full start-up expected Q2 2026; capacity 20,000 t/yr.

1 August 2025
Evonik Reports Q2 Demand Decline

Q2 2025 saw a 12% EBITDA drop due to weak demand, currency effects, and divestments. Revenue fell 11%. Fewer shutdowns and new capacities expected to aid H2.